Wednesday, November 11, 2020, 6:00 PM - 7:30 PM


The goal of this CME activity is to provide physicians and their clinical staff education on how to successfully manage chronic disease in the ambulatory setting, following best practices for classification, medication management, and multi-disciplinary collaboration.

1. Outline optimal ambulatory management and medication considerations for Diabetes Mellitus (DM) type II and Heart Failure (HF)
2. Recognize value of multidisciplinary teamwork to optimize disease management for Diabetes Mellitus (DM) type II and Heart Failure (HF)
3. Understand management consideration for HF sub-types (HFREF, HFPEF, RHF).
4. Outline appropriate usage and considerations for diabetic medications including SGLT2 inhibitors and DPP-4 inhibitors

This activity is complimentary:

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (1.50 hours), Non-Physician Attendance (1.50 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.